We found with IM-9 human cultured lymphocytes, that the glucocorticoid dexamethasone increased insulinreceptor mRNA levels. This increase correlated in a time-and dose-dependent manner with the increase in the biosynthesis of the insulin-receptor precursor. In addition, in AR42J cultured rat pancreatic acinar cells, dexamethasone increased insulin-receptor mRNA levels. These studies suggest, therefore, that an increase in mRNA levels is an early step in the regulation of the insulin receptor by glucocorticoids in several cell types. Diabetes 36:779-81,1987 I nsulin produces a wide range of effects in the intact organism and in cultured cells (1). These effects occur after insulin binds to and activates a tetrameric glycoprotein receptor located on the plasma membrane (2). This receptor consists of two a-subunits and two p-subunits linked by sulfhydryl bonds. One a-and one p-subunit are derived from a common precursor. The insulin receptor is under the control of hormones and metabolic factors (1,2). It is unknown, however, whether regulation of the receptor occurs at the level of gene expression.
Insulin-receptor precursor studies. Studies were carried out as previously described (6) . Briefly, the solubilized and 35 S-labeled receptor precursor was reacted with either normal rabbit serum or rabbit polyclonal anti-insulin-receptor antibody (6) and subjected to electrophoresis on a 6% polyacrylamide gel followed by fluorography. mRNA preparation and Northern transfers. Either 3 x 10 8 IM-9 cells or 5 x 10 8 AR42J cells were washed, and total RNA was prepared from IM-9 cells with proteinase K in the presence of sodium dodecyl sulfate (8) and from AR42J cells by the guanidinium-cesium chloride method (9) . Poly(A) + RNA was obtained by oligo (6t) cellulose chromatography (10) . For Northern transfers, poly(A) + RNA was denatured in formaldehyde, subjected to electrophoresis in 1% agarose, and transferred to nitrocellulose paper (11) . cDNA labeling and hybridizations. Two human insulin-receptor cDNA probes (1 and 4.2 kb; a kind gift from Dr. G. I. Bell, Howard Hughes Medical Institute, Univ. of Chicago, Chicago, IL), spanning the entire open reading frame of the receptor and extending into the poly A region (12) , were labeled by nick translation (11) to specific activities of 10 9 cpm/|xg. The nitrocellulose filters were prehybridized and hybridized and washed as previously described (11) . A probe for p-actin (13) was nick translated and hybridized as described for the insulin receptor. Filters were exposed to Kodak XAR-5 film in the presence of two intensifying screens at -70°C for 16 h for IM-9 cells and 48 h for AR42J cells.
RESULTS AND DISCUSSION
Treatment of IM-9 cells with the potent glucocorticoid dexamethasone enhanced the synthesis of the 190,000-A/f r insulin-receptor precursor protein (Fig. *\A) , with maximal effects occurring after 4 h (Fig. 2) . Dexamethasone stimulated insulin-receptor synthesis one-half maximally at 10 nM and maximally at 100 nM (Fig. 3) . In addition to increasing insulinreceptor protein synthesis, as previously reported (3), dexamethasone induced a time-dependent increase (2-to 3-fold) in 125 l-labeled insulin binding to its receptors. The influence of dexamethasone on insulin-receptor mRNA levels was investigated by employing cDNA probes spanning the coding region of the human insulin receptor ( Fig. 18) . Multiple insulin-receptor mRNAs were observed (4, 5) . In IM-9 cells, dexamethasone increased all insulin receptor mRNAs by 5-to 10-fold. In contrast to this effect on insulin-receptor mRNA, there was no change in the levels of p-actin mRNA (Fig. 1C) . Moreover, both the time course and the dose dependence of the dexamethasone effect on insulin-receptor mRNA levels were similar to the effects of dexamethasone on the synthesis of the insulin-receptor precursor (Figs. 2 and 3) .
To determine whether this effect of dexamethasone on insulin-receptor mRNA levels occurred in other tissues, we studied AR42J rat pancreatic acinar cells, a cell line with characterized insulin receptors (7) . As in IM-9 cells, dexamethasone induced a time-dependent two-to threefold increase in 125 l-insulin binding. In these cells, dexamethasone increased insulin-receptor biosynthesis (data not shown). Moreover, as in IM-9 cells, dexamethasone increased insulin-receptor mRNA levels (Fig. 4) .
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In addition to our in vitro studies with lymphocytes and pancreatic acinar cells, others have reported that glucocorticoids increase insulin-receptor binding and biosynthesis in cultured rat liver cells (14) . In vitro studies with adipose cells and adipose cell precursors have been conflicting (15, 16) , but an increase in receptor biosynthesis has not been reported.
Studies of glucocorticoids in vivo have yielded variable results. We previously reported that glucocorticoids in vivo decrease the binding of insulin to its receptor in liver and other tissues (17) . However, it has also been reported that glucocorticoids in vivo increase insulin-receptor levels (18) . The interpretation of these in vivo studies is complicated by two factors. First, glucocorticoids in vivo raise plasma insulin levels, which consequently downregulate insulin receptors (1, 2) . Second, most studies have employed pharmacological amounts of glucocorticoids that may induce a catabolic state, thus obscuring effects of glucocorticoids on insulinreceptor biosynthesis. Our study with two diverse cell types indicates that glucocorticoids act directly and rapidly on insulin-receptor gene expression. These studies suggest, therefore, that increased synthesis of insulin receptors is a primary effect of glucocorticoids.
